US FDA Safety Labeling Change for mRNA COVID-19 Vaccines
Vinay Prasad, Martin A. Makary
Abstract
This Viewpoint explores the US Food and Drug Administration’s institution of a class Safety Labeling Change for messenger RNA (mRNA) COVID-19 vaccines.
Topics & Concepts
MedicineFood and drug administrationCoronavirus disease 2019 (COVID-19)Messenger RNASevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVirologyRNAPharmacologyGenePathologyGeneticsInfectious disease (medical specialty)DiseaseBiologyOutbreakViral Infections and Immunology ResearchSARS-CoV-2 and COVID-19 ResearchViral gastroenteritis research and epidemiology